SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Monday reported a loss of $7.6 million in its second quarter.
On a per-share basis, the San Francisco-based company said it had a loss of $1.88. Losses, adjusted to account for discontinued operations, came to $3.38 per share.
The biotech drug developer posted revenue of $1.3 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
